14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.58 $5.85 Friday, 3rd May 2024 CTMX stock ended at $4.43. This is 1.56% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 14.22% from a day low at $4.43 to a day high of $5.06.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Jun 18, 2020 $8.25 $8.55 $8.25 $8.47 443 092
Jun 17, 2020 $8.50 $8.59 $8.13 $8.35 327 179
Jun 16, 2020 $8.20 $8.74 $8.09 $8.52 551 503
Jun 15, 2020 $7.77 $8.16 $7.57 $8.04 563 135
Jun 12, 2020 $7.73 $8.11 $7.63 $7.96 1 270 096
Jun 11, 2020 $7.80 $7.85 $7.33 $7.51 775 662
Jun 10, 2020 $8.17 $8.21 $7.89 $7.93 359 642
Jun 09, 2020 $8.30 $8.42 $8.03 $8.05 381 310
Jun 08, 2020 $8.10 $8.45 $7.97 $8.37 508 299
Jun 05, 2020 $8.37 $8.37 $8.04 $8.06 680 330
Jun 04, 2020 $8.02 $8.66 $8.01 $8.16 744 812
Jun 03, 2020 $8.10 $8.27 $7.93 $8.05 602 919
Jun 02, 2020 $8.07 $8.18 $7.78 $8.12 565 307
Jun 01, 2020 $8.58 $8.74 $7.92 $8.06 1 109 153
May 29, 2020 $8.96 $9.24 $8.51 $8.86 715 116
May 28, 2020 $9.04 $9.05 $8.71 $8.73 541 284
May 27, 2020 $9.17 $9.32 $8.75 $9.04 459 432
May 26, 2020 $9.44 $9.47 $8.73 $9.16 1 839 415
May 22, 2020 $9.44 $9.49 $9.09 $9.28 544 658
May 21, 2020 $9.27 $9.67 $9.13 $9.42 402 918
May 20, 2020 $9.24 $9.46 $9.07 $9.31 462 331
May 19, 2020 $9.40 $9.52 $9.00 $9.16 670 084
May 18, 2020 $9.05 $9.61 $8.81 $9.40 929 856
May 15, 2020 $9.33 $9.33 $8.61 $9.01 1 040 773
May 14, 2020 $10.96 $11.29 $8.82 $9.23 2 875 370
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT